Acesso livre
Acesso livre

Obstetrícia/Medicina Fetal

Estudo de coorte | Desfechos neonatais de mães portadoras de alguma deficiência.

12 Ago, 2022 | 17:47h

Neonatal Outcomes of Mothers With a Disability – Pediatrics

Comentário: Risk for Complications Increased for Newborns of Moms With Disability – HealthDay

 


Revisão sistemática | Diferentes corticosteroides e regimes para acelerar a maturação pulmonar fetal em bebês sob risco de nascimento prematuro.

12 Ago, 2022 | 17:25h

Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth – Cochrane Library

Resumo: Different corticosteroid treatments before early birth for improving outcomes for babies – Cochrane Library

 


Revisão sistemática | Risco de desfechos gestacionais adversos antes do início de doença reumática autoimune.

9 Ago, 2022 | 17:09h

Risk of adverse pregnancy outcomes prior to the onset of an autoimmune rheumatic disease: a systematic review – Rheumatology

 


M-A | Fatores de risco para prolapso de órgão pélvico primário e recorrente.

9 Ago, 2022 | 17:02h

Risk factors for primary pelvic organ prolapse and prolapse recurrence: an updated systematic review and meta-analysis – American Journal of Obstetrics & Gynecology

 

Comentário no Twitter

 


Estudo randomizado | Dexametasona antenatal para parto prematuro tardio (entre 34 e 36 semanas de gestação).

9 Ago, 2022 | 16:44h

Antenatal dexamethasone for late preterm birth: A multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial – EClinicalMedicine

 

Comentário no Twitter

 


Estudo randomizado | Seguimento pós-parto de 72 semanas de dolutegravir vs. efavirenz iniciado na gestação.

5 Ago, 2022 | 17:40h

72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study – The Lancet HIV

Conteúdos relacionados:

WHO Recommends Dolutegravir as Preferred HIV Treatment Option in All Populations

Week 96 results from a RCT: Efficacy and safety of dolutegravir or darunavir combined with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection.

RCT: Efficacy and safety of switching to the 2-drug regimen Dolutegravir/Lamivudine vs. continuing a 3- or 4-Drug regimen for maintaining virologic suppression in adults living with HIV-1.

RCT: Low-cost, easy to take antiretroviral treatment based on Dolutegravir as first- or second-Line therapy found to be non-inferior to standard care for treating HIV-1 infection in children.

RCT: Dolutegravir or Darunavir in combination with Zidovudine or Tenofovir to treat HIV.

Randomized controlled trial compared three antiretroviral regimens started in pregnant women with HIV

Randomized Trial: Switching to Dolutegravir/Lamivudine Two-Drug Regimen Noninferior to Continuing a Tenofovir Alafenamide–Based Three- or Four-Drug Regimen for Maintenance of Virologic Suppression in Adults With HIV-1

 


M-A | Pacote de cuidados perioperatórios para prevenção de infecções de sítio cirúrgico.

4 Ago, 2022 | 14:23h

Perioperative care bundles for the prevention of surgical-site infections: meta-analysis – British Journal of Surgery

 


M-A | Parto planejado ou manejo expectante na pré-eclâmpsia.

4 Ago, 2022 | 14:22h

Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis – American Journal of Obstetrics & Gynecology

 

Comentário no Twitter

 


Revisão sistemática de escopo | Estudos randomizados na saúde materna e perinatal em países de baixa e média rendas de 2010 a 2019.

18 Jul, 2022 | 13:09h

Randomised trials in maternal and perinatal health in low and middle-income countries from 2010 to 2019: a systematic scoping review – BMJ Open

 


Relatório | Os primeiros 5 anos do transplante de útero nos EUA.

14 Jul, 2022 | 11:43h

The First 5 Years of Uterus Transplant in the US: A Report From the United States Uterus Transplant Consortium – JAMA Surgery (link para o resumo – $ para o texto completo)

Comentário: Good Outcomes From First 5 Years of Uterus Transplants, But Concerns Remain – U.S.News

 

Comentário no Twitter

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.